Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-22-010391

Senior VP, Finance & CAO acquired 9,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Burns John Thomas Senior VP, Finance & CAO 2022-01-31 Grant or award +9,600 27,244 D
Derivatives
Burns John Thomas Senior VP, Finance & CAO 2022-01-31 Grant or award · Stock Option (Right to Buy) +36,000 36,000 D
Loading xslF345X03/tm225088-1_4seq1.xml…